Giant Cell Arteritis (GCA), or temporal arteritis, is an autoimmune systemic vasculitis targeting large and medium-sized arteries, particularly the ophthalmic, posterior ciliary, and temporal arteries. GCA is the single most urgent ophthalmic emergency: without immediate high-dose corticosteroid treatment, arteritic anterior ischemic optic neuropathy (A-AION) can blind both eyes within hours to days.
Common Symptoms & Clinical Presentation
Patients with giant cell arteritis commonly report one or more of the following characteristic symptoms:
- Sudden, profound, painless vision loss (often "light perception only" or total darkness)
- New-onset localized headache, frequently in the temporal or occipital scalp
- Jaw claudication: fatigue, ache, or cramping in the jaw muscles while chewing
- Scalp tenderness when brushing hair or resting head on a pillow
- Constitutional symptoms: low-grade fever, unexplained weight loss, night sweats, fatigue
- Polymyalgia Rheumatica (PMR) symptoms: proximal shoulder and hip stiffness
Underlying Causes & Mechanisms
Neuro-ophthalmic conditions frequently result from complex interactions between the central nervous system, autoimmune pathways, and vascular circulation:
- Granulomatous transmural inflammation of the arterial wall with fragmentation of the internal elastic lamina
- Age-related autoimmune dysregulation occurring exclusively in adults over 50 years of age
Specialized Diagnostic Workup
An accurate diagnosis requires in-depth tertiary evaluation that correlates visual sensory testing with computerized structural imaging:
- Immediate stat inflammatory markers: ESR (Westergren), high-sensitivity CRP, and Platelet count
- Fundus examination showing pale, chalky-white edematous optic nerve head
- Temporal artery biopsy (unilateral or bilateral, minimum 2 cm segment) for histopathologic confirmation
- Temporal artery duplex ultrasound (evaluating the characteristic hypoechoic "halo sign")
Management & Therapeutic Strategies
Treatment protocols are tailored to the specific etiology and severity of visual risk:
- Immediate administration of high-dose intravenous methylprednisolone (IVMP) followed by oral prednisone
- Never delay steroid initiation to wait for temporal artery biopsy results
- IL-6 receptor antagonist therapy (Tocilizumab / Actemra) for steroid-sparing maintenance
- Gastroprotection and bone protection protocols alongside long-term immunosuppression
Frequently Asked Questions
Temporal artery biopsy remains the definitive gold standard for diagnosing GCA. Because corticosteroid therapy carries significant side effects and must be continued for 12 to 24 months, histologic proof provides indispensable legal and clinical certainty.
True visual recovery in an eye affected by arteritic AION is rare due to complete infarction of the optic nerve head. The urgent goal of treatment is immediate preservation of vision in the fellow eye.